首页> 外文期刊>BMC Musculoskeletal Disorders >Comprehensive assessment of knee joint synovitis at 7?T MRI using contrast-enhanced and non-enhanced sequences
【24h】

Comprehensive assessment of knee joint synovitis at 7?T MRI using contrast-enhanced and non-enhanced sequences

机译:使用对比度增强和非增强序列综合评估7?T MRI的膝关节滑膜炎

获取原文
           

摘要

Background: Seven T ultra-high field MRI systems have recently been approved for clinical use by the U.S. andEuropean regulatory agencies. These systems are now being used clinically and will likely be more widely availablein the near future. One of the applications of 7 T systems is musculoskeletal disease and particularly peripheralarthritis imaging. Since the introduction of potent anti-rheumatic therapies over the last two decades MRI hasgained increasing importance particularly for assessment of disease activity in early stages of several rheumaticdisorders. Commonly gadolinium-based contrast agents are used for assessment of synovitis. Due to potential sideeffectsof gadolinium non-enhanced techniques are desirable that enable visualization of inflammatory diseasemanifestations. The feasibility of 7 T MRI for evaluation of peripheral arthritis has not been shown up to now. Aim ofour study was to evaluate the feasibility of contrast-enhanced (CE) and non-enhanced MRI at 7 T for the assessmentof knee joint synovitis.Method: Seven T MRI was acquired for 10 patients with an established diagnosis of psoriatic or rheumatoid arthritis.The study pulse sequence protocol was comprised of a sagittal intermediate-weighted fat-suppressed (FS), axialfluid-attenuated inversion recovery (FLAIR) FS, sagittal 3D T1-weighted dynamic contrast enhanced (DCE) and anaxial static 2D T1-weighted FS contrast-enhanced sequence (T1-FS CE). Ordinal scoring on non-enhanced (Hoffaandeffusion-synovitis) and enhanced MRI (11-point synovitis score), and comparison of FLAIR-FS with static T1-FSCE MRI using semiquantitative (SQ) grading and volume assessment was performed. For inter- and intra-readerreliability assessment weighted kappa statistics for ordinal scores and intraclass correlation coefficients (ICC) forcontinuous variables were used.Results: The total length of study protocol was 15 min 38 s. Different amounts of synovitis were observed in allpatients (mild: n = 3; moderate: n = 5; severe: n = 2). Consistently, SQ assessment yielded significantly lowerperipatellar summed synovitis scores for the FLAIR-FS sequence compared to the CE T1-FS sequence (p 0.01).FLAIR-FS showed significantly lower peripatellar synovial volumes (p 0.01) compared to CE T1-FS imaging with anaverage percentage difference of 18.6 ± 9.5%. Inter- and intra-reader reliability for ordinal SQ scoring ranged from0.21 (inter-reader Hoffa-synovitis) to 1.00 (inter-reader effusion-synovitis). Inter- and intra-observer reliability of SQ3D-DCE parameters ranged from 0.86 to 0.99.Conclusions: Seven T FLAIR-FS ultra-high field MRI is a potential non-enhanced imaging method able to visualizesynovial inflammation with high conspicuity and holds promise for further application in research endeavors andclinical routine by trained readers.
机译:背景:最近批准了七吨超高场MRI系统,供美国安安氏监管机构批准临床使用。这些系统现在正在临床上使用,并且可能更广泛地可用在不久的将来。 7 T系统的应用之一是肌肉骨骼疾病,特别是外周关节炎成像。由于在过去二十年中引入了有效的抗风湿疗法,因此MRI显着越来越重要,特别是在几种风湿差异的早期阶段评估疾病活动。基于Gadolinium的造影剂用于评估滑膜炎。由于钆非增强技术的潜力缺口,希望能够可视化炎症性抑制道道。现在没有显示7 T MRI用于评估外周关节炎的可行性。 OROU的研究是评估膝关节联合Synovitis的评估中对比增强(CE)和非增强MRI的可行性。方法:10名患者的诊断诊断,患有七吨的银屑病或类风湿性关节炎患者。研究脉冲序列方案由矢状中等加权脂肪抑制(FS),轴向杂于衰减反演恢复(FLAIR)FS,矢状3D T1加权动态对比增强(DCE)和anaxial静态2D T1加权FS对比度-NenHanced序列(T1-FS CE)。对非增强(Hoffaandeffusion-Synovitis)和增强的MRI(11点滑膜炎评分)的顺序评分,并进行了使用半定量(SQ)分级和体积评估的静态T1-FSCE MRI的Flair-FS的比较。对于序数分数的相互作用和内交叉性评估,使用序数分数和脑内相关系数(ICC)的核统计数据被使用。结果:研究方案的总长度为15分38秒。在血液分流中观察到不同量的滑膜炎(温和:n = 3;中等:n = 5;严重:n = 2)。始终如一地,与CE T1-FS序列(P <0.01)序列相比,SQ评估产生明显低于FLAIR-FS序列的SYGOVITIS SCOVINGS分数成像厌恶率百分比差为18.6±9.5%。序数SQ刻痕的间和读取器间可靠性范围为0.21(互相互际Hoffa-Synovitis)至1.00(互相互相渗透 - 滑膜炎)。 SQ3D-DCE参数的观察者间和观察者内部的可靠性范围为0.86至0.99。结论:七个FLAIR-FS超高场MRI是一种能够具有高层炎症的潜在的非增强成像方法,并持有进一步的承诺在研究中的应用致力于训练读者循环常规。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号